Company intelligence / Profile preview

Boston Healthcare

Cambridge, Massachusetts, United States

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Boston Pharmaceuticals is a clinical-stage biopharmaceutical company that has demonstrated promising Phase 2 results for its lead candidate, BOS-580, in patients with MASH (formerly NASH). Trials showed significant reductions in liver fat content and improvements in non-invasive markers of liver injury and fibrosis. The company also has active Phase 2 programs in immunology, specifically for atopic dermatitis.

Therapeutic areas: DermatologyGastroenterologyMetabolic Disorders
Modalities: Small moleculeMonoclonal antibodyRecombinant proteinFusion protein
Industry: Biotech

Partnerships

NovartisGlaxoSmithKlineSanofi

Beyond the preview

Go deeper on Boston Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Boston Healthcare.

Explore the full profile